This opportunity is no longer accepting applications.
grant PAR-24-172

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

This grant opportunity is for researchers to conduct phase I clinical trials focusing on diagnostic and therapeutic interventions for heart, lung, blood, and sleep disorders in both adults and children. Trials can be carried out at one or multiple sites. Applicants must be prepared to start the clinical trial within the first three months of funding. Before funding is awarded, all necessary re…

The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. The proposed trial can be single or multisite. Applicants applying for f…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Heart, Lung, and Blood Institute
Program: SBIR

Awards & funding

Award Ceiling: $1.5M
Award Amount: $1.5M

Dates

Opportunity Released: April 1, 2024
Open for Submission: April 1, 2024
Submission Deadline: January 7, 2027
Application Window Closes: January 7, 2027

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.